ara A Hurvitz, MD, FACP Associate Professor of Medicine Director, Breast Oncology, explains Not Using Anthracycline-based Therapies Patients accumulate loss of heterozygosity & MSI at the 2018 Oncology Summit in Huntington Beach, CA
Go to: http://www.moasc.org for more information
Advertisement